Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A2YNT30
Wed, 02.10.2024
Alzchem Group AG
Alzchem Group AG plans to double nitroguanidine production capacity in Germany
Trostberg, October 2, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, plans to significantly increase its production capacity for nitroguanidine. It was only in spring of this year t [ … ]
Wed, 02.10.2024
Alzchem Group AG
Trostberg, October 2, 2024 – Alzchem Group AG plans significantly increase its production capacity for nitroguanidine. It was only in spring of this year that the company announced a capacity expansion for the preliminary stage with an investment of EUR 76 million over several years. Taking into account the additional expansion plans for a new prod [ … ]
Tue, 01.10.2024
Alzchem Group AG
Alzchem Group AG set to join the SDAX on October 2, 2024
Trostberg, October 1, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, will be included in the SDAX selection index for the first time on October 2, 2024. This makes Alzchem one of the 160 largest and most [ … ]
Thu, 01.08.2024
Alzchem Group AG
Alzchem Group AG: Continued strong growth in Specialty Chemicals business leads to significant EBITDA increase of 41.2% to EUR 51.9 million in the first half of 2024
Half-year result climbs by 78.4% to EUR 26.7 million
Free cash flow increases by 64.5% to EUR 51.4 million
Management Board raises earnings forecasts for the full year 2024
Trostbe [ … ]
Tue, 30.07.2024
Alzchem Group AG
Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
Trostberg, July 30, 2024 – Alzchem Group AG is raising its earnings forecasts for fiscal year 2024. Group EBITDA will grow to over EUR 100 million with unchanged sales expectations (original forecast: approx. EUR 90 million). The raise in the EBITDA forecast leads t [ … ]
Fri, 07.06.2024
Alzchem Group AG
Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand
Trostberg, June 7, 2024 – Alzchem has received funding commitments totaling around EUR 850 thousand, which represent non-repayable investment grants this year. Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading mark [ … ]
Tue, 07.05.2024
Alzchem Group AG
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th [ … ]
Tue, 07.05.2024
Alzchem Group AG
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th [ … ]
Tue, 30.04.2024
Alzchem Group AG
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
Result for the period increases significantly by 58.7% to EUR 12.2 million
Strong free cash flow of EUR 26.6 million
Management Board confirms forecasts for the full year 2024
Trostberg, April 30, 2024 – Alzchem Group AG, a [ … ]
Fri, 15.03.2024
Alzchem Group AG
Trostberg, 15 March 2024 - Following a Europe-wide selection process, Alzchem Group AG has been awarded an investment grant of EUR 34.4 million by the EU Commission as part of the ASAP ("Act in Support of Ammunition Production") funding instrument.
Alzchem Group AG wants to use the funds over an investment period of two and a half years to increase [ … ]